(a)
Definitions
(1) This regulation
defines the method of reimbursement of clinical diagnostic laboratory services
provided by acute care hospitals to Connecticut Medical Assistance
recipients.
(2) For the purposes of
this regulation, "Clinical Diagnostic Laboratory Services" means those clinical
diagnostic laboratory tests and related specimen collections subject to the
statewide Clinical Diagnostic Laboratory Test Fee Schedule established by the
State Medicare carrier for outpatient hospital-based laboratories effective
July 1, 1984 in accordance with Section 2303 of Public Law
98-369. The
procedures covered by this definition shall include or exclude any subsequent
additions or deletions made by the State Medicare carrier for outpatient
hospital-based laboratories. Each test covered is identified and described
using the Health Care Financing Administration Common Procedures Coding System
(HCPCS) five (5) digit procedure code and terminology or local codes and
descriptions assigned by the State Medicare carrier.
(3) "Hospital Outpatient" means a person who
has not been admitted by the hospital as an inpatient but is registered on the
hospital records as an outpatient and is directly receiving outpatient hospital
services (rather than supplies alone). Where the hospital uses the category
"day patient," i.e., a person who directly receives hospital services during
the day and is not expected to be lodged in the hospital at midnight, the
individual is classified as an outpatient.
(4) "Hospital Nonpatient" means a person who
is not registered on the hospital records as an outpatient or is not directly
receiving services from the hospital but the hospital provides all or part of
the required testing.
(5) For the
purposes of these regulations, "hospital" means acute care Connecticut-based or
border hospital.
(6) "Department"
means the Department of Income Maintenance.
(7) "Rate Year" means beginning January 1,
1987 the Medicaid rate year shall be concurrent with the Medicare rate
year.
(b)
Services
Covered
Clinical Diagnostic Laboratory Services, as defined in these
regulations, and Specimen Collection Fees, as provided in these regulations,
are eligible for payment as set forth below provided the requirements set forth
below are met.
(c)
Services Not Subject to the Fee Schedule
Laboratory tests not subject to the fee schedule pursuant to
this regulation include:
(1)
Laboratory tests furnished to a hospital inpatient as defined in § 150.1B
of the Department's Medical Services Policy Manual;
(2) Those laboratory tests furnished by
hospital-based end-stage renal dialysis (ERSD) facilities the cost of which are
included in the ERSD composite rate payment;
(3) Laboratory tests and services as
identified by the State Medicare carrier to be performed by a physician;
and
(4) Certain blood tests and
test primarily associated with the provision of blood products as identified by
the State Medicare carrier.
(d)
Need for Service
In order to be eligible for reimbursement any clinical
diagnostic laboratory service performed and for which payment is sought must be
reasonable, necessary, and furnished under the direction of a physician for the
diagnosis or treatment of a particular illness or injury of the patient upon
whom the test was performed.
(e)
Payment Rate
(1) Pursuant to Section 2303 (g) (2) and (j)
(2) of Public Law
98-369 enacted effective July 18, 1984, clinical diagnostic
laboratory services provided to hospital outpatients and nonpatients and
performed on and after July 1, 1984 and paid on or after October 1, 1984 shall
be reimbursed no more than the statewide fee schedule for clinical diagnostic
laboratory tests, including amounts for specimen collections as permitted under
these regulations, established by the State Medicare carrier for
outpatient/nonpatient hospital-based laboratories; or the amount of the charges
billed for the tests. Effective for outpatient clinical laboratory services
rendered on or after July 1, 1986, the rate shall be the lesser of the amount
determined under such Medicare fee schedule, the limitation amount for that
test pursuant to Section 9303 (b) of the Public Law
99-272 enacted effective
July 1, 1986, or the amount of the charges billed for the tests;
(2) In order to remain in compliance with
Section 2303 (g) (2) and (j) (2) of Public Law
98-369 for the rate period July
1, 1985 through June 30, 1986 and Section 9303 (b) of the Public Law
99-272
enacted effective July 1, 1986 for the rate period July 1, 1986 through
December 31, 1986 and the current rate year, i.e., January 1, 1987 through
December 31, 1987 and all subsequent Medicare rate years, the rates for
clinical diagnostic laboratory services as defined in these regulations shall
be reimbursed as follows:
(A) For the
Medicare rate period July 1, 1985 through June 30, 1986, payments by the
Department shall be made in accordance with the Medicare Fee Schedule as it
existed on July 1, 1985. The rates established by the Department shall be the
lesser of the Medicare Fee Schedule for such period or the amount of the
charges billed for the tests;
(B)
For the Medicare rate period July 1, 1986 through December 31, 1986, the rates
established by the Department shall be the lesser of the Medicare Fee Schedule
in effect on July 1, 1985, the limitation amount pursuant to Section 9303 (b)
of the Public Law
99-272 for the amount of the charges billed for the
tests.
(C) For the Medicare rate
period beginning on and after January 1, 1987, the rates of payment shall be
based upon the lesser of the amount of the Medicare Fee Schedule, the
limitation amount pursuant to Section 9303 (b) of the Public Law
99-272 or the
amount of the charges billed for the tests;
(D) Any subsequent changes mandated by
Congress or of the United States Department of Health and Human Services shall
be implemented by the Department as soon as practicable retroactive to the
effective date of said mandatory change.
(f)
Payment Limitations
(1) The amount paid by the Department for the
clinical diagnostic laboratory services including amounts for specimen
collections as permitted under these regulations constitutes payment in full to
the provider hospital.
(2) There is
no payment of Medicare coinsurance and deductible for clinical diagnostic
laboratory tests subject to these regulations.
(3) When the hospital obtains laboratory
tests for outpatients or nonpatients under arrangements with independent
laboratories or other hospital laboratories, either the originating hospital
(or hospital laboratory) may receive payment for all tests, or the originating
hospital and the reference laboratories may receive payment for the tests they
perform. The hospital may not receive payment for tests under arrangement if it
does not operate a laboratory.
(4)
Pursuant to said Section 2303 (g) (2) and (j) (2) of Public Law
98-369, it will
be necessary to verify that any amounts expended by the Department between
October 1, 1984 and January 31, 1986 inclusive, for clinical diagnostic
laboratory tests did not exceed the amount that would be recognized under the
Social Security Act by Medicare. If any such payments are found to exceed the
amount permitted by Federal law, said amounts shall be adjusted so as not to
exceed the maximum amount permitted by Federal law.
(5) The methodology to be employed to
accomplish this verification in subsection (f) (4) of these regulations will be
one of the two methodologies set forth below at the election of the hospital.
However, once a hospital has elected one methodology it may not wait for the
results of that methodology and then request the other methodology. Each
hospital must notify the Department of its election by March 31, 1986. Failure
of a hospital to provide notification of said election or failure of a hospital
to provide the necessary information required by whichever option the hospital
has selected may result in the Department's deferral of payment for clinical
diagnostic laboratory services of that hospital until said hospital has
furnished the required information.
METHOD I
(6) The Department will take a random sample
of claims paid for clinical diagnostic laboratory services under the applicable
UB82 revenue codes for each hospital using the Department's claims payment
history for each hospital. The sample will be randomly taken from all hospital
claims paid using the summary, ratio-to-cost methodology and for which payment
was made by the Department on or after October 1, 1984 for dates of service
between July 1, 1984 and January 31, 1986 inclusive. The claims data base will
be collected until the Department, at its sole discretion, determines that a
sufficient number of clinical tests within said dates of service have been
paid. The Department will provide each hospital with a record of each recipient
claim payment included in the sample. The record will show the amount billed by
the hospital, dates of service, the amount paid, and the date of payment by the
Department for each applicable revenue code. This method will require the
hospitals to provide to the Department a corresponding report indicating the
details of each recipient claim in the sample. The detail report must include:
(A) the recipient's name and Medicaid
identification number;
(B) the
HCPCS for each test in the sample claim;
(C) the corresponding fee schedule rate, if
available, and hospital charge for each test in the sample claim;
(D) date of service of each test and specimen
collection;
(E) the total of the
above details including the totals of the amounts that would have been billed
and the amount that would have been paid using the Medicare Fee Schedule (if
available);
(F) the hospital should
report applicable specimen collection fees in the same manner as described
above as long as the collection fees are in conformance with the specimen
collection section below;
(G) it is
possible that some of the sample claims selected may represent a mixture of
tests which are subject to, and tests which are not subject to, the Medicare
Fee Schedule. The total charges for the tests which are not subject to the
Medicare fee schedule must also be set forth on the hospital's detail report in
order to reconcile the total of the charges on this report with the total
charges on the Department's claims sample report sent to the hospital. Details
for tests not subject to the fee schedule, as provided for in these
regulations, need only show the aggregate amount billed.
(H) the Department will compare the ratio of
the total amount billed by the hospital and paid by the Department with the
ratio of the total amount billed by the hospital and paid using the Medicare
Fee Schedule. The ratio of the amount paid to the amount billed is the percent
of the amount billed to the amount paid. If the ratio resulting from the
Department's sample claims is larger than the ratio resulting from the
hospital's details of the sample claims using the fee schedule, an overpayment
will exist. To determine the actual amount of the overpayment, the total amount
billed by the hospital corresponding to the claims paid for the period
beginning October 1, 1984 through January 31, 1986 will be multiplied by the
ratio resulting from the total amounts calculated from the hospital's detailed
report. If the total actually paid for said period is greater than the amount
calculated to be the amount the Department should have paid, the resulting
difference between said amounts shall be the total amount of the overpayment
for clinical diagnostic laboratory services paid to the hospital for the period
October 1, 1984 through January 31, 1986. If the Department determines that the
hospital has been overpaid, the Department shall notify the hospital. If
payment arrangements satisfactory to the Department are not made by the
hospital within thirty (30) days of said notification, the Department, in its
sole discretion, may recoup the overpayment from the next payment or payments
due from the Department to the hospital.
METHOD II
(7) At the election of the hospital, the
Department will collect claims data for clinical diagnostic laboratory services
from each hospital's record of payments for a sample period. The sample period
will reflect claims paid at the current Medicare fee schedule including related
specimen collection fees which meet the requirements of the specimen collection
section below. The sample period shall include dates of service for a three
month period beginning February 1, 1986 through April 30, 1986 which have been
paid pursuant to the Medicare Fee Schedule.
(A) The Department will use its Medicaid
Management Information System (MMIS) to collect the data necessary to determine
any overpayment. The data will be collected until the Department, in its sole
discretion, determines that a sufficient number of clinical tests with dates of
services within the sample period have been paid.
(B) The data to be collected will be the
total of the amounts billed by each hospital during the sample period and the
total amount paid by the Department to each hospital covering dates of service
in the same period. The amount billed should represent the hospital's usual and
customary charges for clinical laboratory services and the Department's payment
will be the amounts allowed in accordance with the current Medicare Fee
Schedule.
(i) For the retroactive period
covered by dates of service commencing July 1, 1984 (and paid by the Department
on or after October 1, 1984) through June 30, 1985, the total amount billed in
the sample period shall be adjusted for any across-the-board changes in the
hospital's usual and customary charges set for clinical diagnostic laboratory
services subject to the Medicare Fee Schedule and occurring on and after July
1, 1985. If such increases occurred, the hospital will be required to furnish
the Department with the following information regarding its usual and customary
charge history for clinical diagnostic laboratory services and specimen
collection fees as defined in these regulations during the period July 1, 1985
through April 30, 1986:
(aa) the date(s) the
across-the-board charge rate change(s) became effective between July 1, 1985
and April 30, 1986;
(bb) the amount
of across-the-board change, e.g., percent or dollar amount.
The total amount paid for the sample period will be adjusted
by the amount of the Medicare Fee Schedule rate increase which became effective
July 1, 1985. The ratio of the adjusted amounts billed to the adjusted amount
paid during the sample period shall represent the ratio of the total amount
that should have been billed and paid during the aforementioned retroactive
period for clinical laboratory services. Said ratio will be applied to the
total amount actually billed by the hospital for the aforementioned retroactive
period. The resulting amount shall represent the total amount which the
Department should have paid to the hospital in said period. If the total amount
which was actually paid to the hospital for said period is greater than the
amount calculated to be the amount the Department should have paid, the
resulting difference between said amounts shall be the amount of the
overpayment for clinical diagnostic laboratory services paid to the hospital
for said retroactive period.
(ii) For the retroactive period beginning
with dates of service July 1, 1985 through January 31, 1986, the unadjusted
ratio calculated from the actual amount billed and paid for the sample period
shall be applied to the total amount billed for said retroactive period. If the
total amount which was actually paid to the hospital for said retroactive
period is greater than the amount calculated to be the amount the Department
should have paid, the resulting difference between said amounts shall be the
total amount of the overpayment for clinical diagnostic laboratory services
paid to the hospital for said retroactive period.
(iii) The Department shall notify the
hospital of the overpayment resulting from either or both retroactive periods.
If payment arrangements are not made by the hospital within thirty (30) days of
said notification satisfactory to the Department, the Department in its sole
discretion, may recoup said overpayment(s) from the next payment or payments
due from the Department to the hospital.
(iv) If the amount of difference for either
retroactive period utilizing Method I or Method II reveals that the Department
paid less than would have been paid pursuant to Medicare, no payment shall be
made by the Department to the hospital.
(8) Should any claims for clinical diagnostic
laboratory services rendered prior to February 1, 1986 be submitted after the
date that any overpayment has been calculated, the ratio used in determining
the overpayment using either Method I or Method II shall be applied in
calculating the amount of reimbursement for said services.
(9) Pursuant to said Section 9303 (b) of the
Public Law
99-272, it will be necessary to verify that any amounts expended by
the Department for dates of service on and after July 1, 1986 and received for
payment on or before November 30, 1986, for clinical diagnostic laboratory
tests did not exceed the amount that would be recognized under said Section. If
any such payments are found to exceed the amount permitted by Federal law, said
amounts shall be adjusted so as not to exceed the maximum amount permitted by
Federal law.
(10) Such amount of
overpayment found pursuant to subsection (f) (9) of these regulations will be
recouped from the next payment or payments due from the Department to the
hospital.
(g)
Specimen Collections
(1) Payment
for drawing or collecting specimens is allowed for those hospitals who have an
established rate and routinely charge for specimen collections.
(2) The payment of specimen collections is
the lower of:
(A) the Medicare rate;
(B) the Medicaid prevailing rate;
and
(C) the hospital's usual and
customary charge.
(3)
Payment will be made only in those cases in which the hospital has drawn or
collected the specimen from the patient.
(4) Only one (1) collection fee is allowed
for each type of specimen (e.g., blood, urine, etc.) for the same patient
encounter regardless of the number of specimens drawn or collected.
(5) Payment is allowed in circumstances such
as drawing blood samples through venipuncture (i.e., inserting into vein a
needle with syringe or vacutainer to draw the specimen) or collecting a urine
sample by catheterization.
(6) When
a series of specimens is required to complete a single test (e.g., glucose
tolerance test), the series is treated as a single encounter.
(7) A specimen collection fee is not allowed
for samples where the cost of collecting the specimen is minimal (such as a
throat culture, a routine capillary puncture for clotting, or bleeding
time).
(8) A specimen collection
fee is allowed when it is medically necessary for a laboratory technician to
draw a specimen from either a nursing home patient or homebound patient. The
technician must personally draw the specimen, e.g., venipuncture or sample by
catheterization. A specimen collection fee is not allowed the visiting
technician where a patient in a facility is not confined to the facility or the
facility has on duty personnel qualified to perform the specimen collection. It
must be indicated in the SNF patient record that no staff is available to draw
the sample.
(9) The amount allowed
by the Department for drawing or collecting a specimen at the laboratory
facility covers the specimen drawing service and materials and supplies
used.
(10) The amount allowed for
drawings done in the recipient's home or in a nursing home covers the travel
expenses of the technician, specimen drawing service, and materials and
supplies used.